This review covers disease background and current therapies, pharmacodynamics, efficacy and tolerability, drug interactions and key studies featuring brivaracetam use.
Commentary has been provided by Professor Mark Cook, Director of Neurology at St. Vincent’s Hospital Melbourne, and a neurologist specialising in the treatment of epilepsy.
Please login below to download this issue (PDF)